Showing 1 - 7 results of 7 for search 'Ramsingh, G', query time: 0.03s
Refine Results
-
1
-
2
-
3
-
4
A phase 3, randomized, open-label study evaluating the safety and efficacy of magrolimab in combination with azacitidine in previously untreated patients with TP53-mutant acute mye... by Daver, N, Vyas, P, Chao, MP, Xing, G, Renard, C, Ramsingh, G, Sallman, DA, Wei, AH
Published 2022Conference item -
5
-
6
AML-464 Tolerability and efficacy of the first-in-class anti-CD47 antibody magrolimab combined with azacitidine in frontline patients with TP53-mutated acute myeloid leukemia (AML)... by Daver, N, Vyas, P, Kambhampati, S, Malki, MA, Larson, R, Asch, A, Mannis, G, Chai-Ho, W, Tanaka, T, Bradley, T, Jeyakumar, D, Wang, E, Xing, G, Chao, M, Ramsingh, G, Renard, C, Lal, I, Zeidner, J, Sallman, D
Published 2022Conference item -
7
MDS-482 Impact of magrolimab in combination with azacitidine on red blood cells (RBCs) in patients with higher-risk myelodysplastic syndromes (HR MDS) by Chen, J, Johnson, L, McKenna, K, Choi, T, Duan, J, Feng, D, Tsai, J, Garcia-Martin, N, Sompalli, K, Maute, R, Vyas, P, Majeti, R, Takimoto, C, Liu, J, Ramsingh, G, Chao, M, Volkmer, J-P, Weissman, I
Published 2022Conference item